Levicatus Mugenyi
Overview
Explore the profile of Levicatus Mugenyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mugenyi L, Tembo M, Nelson K, Thomas K, Kansiime C, Lagony S, et al.
BMJ Open
. 2024 Dec;
14(12):e087438.
PMID: 39638588
Introduction: A greater choice of menstrual products may improve menstrual health (MH). This study assessed factors associated with declining consent to receive a menstrual cup by parents and female students...
2.
Turyahabwe S, Bamuloba M, Mugenyi L, Amanya G, Byaruhanga R, Imoko J, et al.
Bull World Health Organ
. 2024 May;
102(6):400-409.
PMID: 38812802
Objective: To assess the effectiveness of a community-based tuberculosis and leprosy intervention in which village health teams and health workers conduct door-to-door tuberculosis screening, targeted screenings and contact tracing. Methods:...
3.
Alupo P, Mugenyi L, Katagira W, Kayongo A, Nalunjogi J, Siddharthan T, et al.
BMJ Open Respir Res
. 2024 Mar;
11(1).
PMID: 38490695
Introduction: Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with varied clinical and pathophysiological characteristics. Although there is increasing evidence that COPD in low-income and middle-income countries may have...
4.
Kirenga B, Chakaya J, Yimer G, Nyale G, Haile T, Muttamba W, et al.
J Allergy Clin Immunol Glob
. 2024 Feb;
3(2):100209.
PMID: 38328803
Background: Severe asthma is associated with high morbidity, mortality, and health care utilization, but its burden in Africa is unknown. Objective: We sought to determine the burden (prevalence, mortality, and...
5.
Mugenyi L, Namuwenge P, Ouma S, Bakashaba B, Nanfuka M, Zech J, et al.
PLoS One
. 2024 Jan;
19(1):e0296239.
PMID: 38166009
Background: Tuberculosis (TB) remains the leading cause of death among people living with HIV (PLHIV). To prevent TB among PLHIV, the Ugandan national guidelines recommend Isoniazid Preventive Therapy (IPT) across...
6.
Mugenyi L, Hansen C, Mayaud P, Seeley J, Newton R, Nanfuka M, et al.
Front Public Health
. 2023 Jun;
11:1187274.
PMID: 37361157
We examined the effect of the Universal Test and Treat (UTT) policy on the characteristics of people living with HIV (PLHIV) at enrolment in HIV care and initiation of antiretroviral...
7.
Kirenga B, Mugenyi L, Sanchez-Rico M, Kyobe H, Muttamba W, Mugume R, et al.
Mol Psychiatry
. 2023 Mar;
28(12):5411-5418.
PMID: 36869228
Prior research suggests that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) used for the treatment of obsessive-compulsive disorder and major depressive disorder, could be repurposed against COVID-19. We undertook a...
8.
Mijumbi A, Mugenyi L, Nanfuka M, Agaba C, Ochieng J
BMC Health Serv Res
. 2023 Feb;
23(1):119.
PMID: 36740683
Background: Community advisory structures such as Community Advisory Boards (CABs) play an important role of helping researchers to better understand the community at each phase of the clinical trial. CABs...
9.
Martins A, Herzog S, Mugenyi L, Faes C, Hens N, Abrams S
Malar J
. 2022 Dec;
21(1):380.
PMID: 36496382
BACKGROUND : In spite of the global reduction of 21% in malaria incidence between 2010 and 2015, the disease still threatens many lives of children and pregnant mothers in African...
10.
Kaddumukasa M, Bongomin F, Mugenyi L, Kiyingi M, Katabira E, Sajatovic M
Medicine (Baltimore)
. 2022 Oct;
101(41):e31012.
PMID: 36254004
There is limited data on the prevalence of seizures and dementia among older persons in Uganda. We evaluated cognitive functioning, and the prevalence and factors associated with seizures among older...